← FDA Drug Approvals (Drugs@FDA)

PITAVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2023-11-20

Drug application

FDA Application #
ANDA206029
Application type
Abbreviated New Drug Application (Generic)
Brand name
PITAVASTATIN CALCIUM
Generic name
Pitavastatin Calcium
Active ingredients
PITAVASTATIN CALCIUM
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
LUPIN
First approval
2023-11-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown